Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway

Molecular and Cellular Biochemistry

Volumn 317, Issue 1-2, 2008, Pages 189-196

  Bao, Yingxia ^a   Li, Ruifang ^a   Jiang, Jianmin ^a   Cai, Birong ^a   Gao, Jie ^a   Le, Kang ^a   Zhang, Fangyan ^a   Chen, Shaorui ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Calcineurin; Cardiac hypertrophy; Endothelin 1; Nuclear factor of activated T cell; Peroxisome proliferator activated receptor gamma

Indexed keywords

CALCINEURIN; ENDOTHELIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GENE ACTIVATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOPRECIPITATION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; RAT;

ANIMALS; ANIMALS, NEWBORN; CALCINEURIN; CARDIOMEGALY; CELL NUCLEUS; CELL SIZE; CYCLOSPORINE; ENDOTHELIN-1; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; PPAR GAMMA; PROTEIN BIOSYNTHESIS; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SURFACE PROPERTIES; THIAZOLIDINEDIONES;

RATTUS;

EID: 53149117031     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9848-8     Document Type: Article

References (39)

1. Izumo S, Aoki H (1998) Calcineurin - the missing link in cardiac hypertrophy. Nat Med 4:661-662. doi: 10.1038/nm0698-661
2. Kota BP, Huang TH-W, Roufogalis BD (2005) An overview on biological mechanisms of PPARs. Pharmacol Res 51:85-94. doi: 10.1016/ j.phrs.2004.07.012
3. Bishop-Bailey D, Hla T (1999) Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12,14-prostaglandin J2. J Biol Chem 274:17042-17048. doi: 10.1074/jbc.274.24.17042
4. Diep QN, Mabrouk ME, Cohn JS et al (2002) Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats role of peroxisome proliferator-activated receptor-γ. Circulation 105:2296-2302. doi: 10.1161/ 01.CIR.0000016049.86468.23
5. Sakai S, Miyauchi T, Irukayama-Tomobe Y et al (2002) Peroxisome proliferator-activated receptor-γ activators inhibit endothelin-1-related cardiac hypertrophy in rats. Clin Sci 103:16S-20S
6. Asakawa M, Takano H, Nagai T et al (2002) Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 105:1240-1246. doi: 10.1161/hc1002.105225
7. Diep QN, Amiri F, Benkirane K et al (2004) Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke prone spontaneously hypertensive rats. Can J Physiol Pharmacol 82:976-985. doi: 10.1139/y04-094
8. Yamamoto K, Ohki R, Lee RT et al (2001) Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 104:1670-1675. doi: 10.1161/ hc4001.097186
9. Molkentin JD, Lu J-R, Antos CL et al (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228. doi: 10.1016/S0092-8674(00)81573-1
10. 2-terminal kinase activation in the heart. J Biol Chem 275:13571-13579. doi: 10.1074/jbc.275.18.13571
11. 2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res 63:450-457. doi: 10.1016/ j.cardiores.2004.04.002
12. Zou Y, Hiroi Y, Uozumi H et al (2001) Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy. Circulation 104:97-101. doi: 10.1161/hc2601.090987
13. Wilkins BJ, Molkentin JD (2004) Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322:1178-1191. doi: 10.1016/j.bbrc.2004.07.121
14. 4+ T cells by PPAR-γ ligands: Involvement of physical association between PPAR-γ and the nuclear factor of activated T cells transcription factor. Mol Pharmacol 64:1169-1179. doi: 10.1124/mol.64.5.1169
15. Liu L, Clipstone NA (2007) Prostaglandin F2α inhibits adipocyte differentiation via a Gαq-calcium-calcineurin-dependent signaling pathway. J Cell Biochem 100:161-173. doi: 10.1002/jcb.21044
16. Yang TTC, Xiong Q, Enslen H et al (2002) Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases. Mol Cell Biol 22:3892-3904. doi: 10.1128/MCB.22.11.3892-3904.2002
17. Bishop-Bailey D (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129:823-834. doi: 10.1038/ sj.bjp.0703149
18. Fu JJ, Gao J, Pi RB et al (2005) An optimized protocol for culture of cardiomyocyte from neonatal rat. Cytotechnology 49:109-116. doi: 10.1007/ s10616-006-6334-6
19. Xu C, Wang L, Liu H et al (2006) C333H, a novel PPARα/γ dual agonist, has beneficial effects on insulin resistance and lipid metabolism. Acta Pharmacol Sin 27:223-228. doi: 10.1111/ j.1745-7254.2006.00263.x
20. Chena M, Lia X, Dongb Q et al (2005) Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats. Regul Pept 125:9-15. doi: 10.1016/j.regpep. 2004.07.034
21. Liao W, Wang S, Han C et al (2005) 14-3-3 Proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy. FEBS J 272:1845-1854. doi: 10.1111/j.1742-4658.2005.04614.x
22. Takayoshi O, Hiroyuki W, Manabu M et al (2007) Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol Cell Cardiol 42:498-507. doi: 10.1016/j.yjmcc.2006.10.020
23. Lu Y, Shioda N, Han F et al (2007) Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes. Biochem Pharmacol 74:1727-1737. doi: 10.1016/j.bcp. 2007.08.022
24. Li R, Zheng W, Pi R et al (2007) Activation of peroxisome proliferator-activated receptor-α prevents glycogen synthase 3β phosphorylation and inhibits cardiac hypertrophy. FEBS Lett 581:3311-3316. doi: 10.1016/j.febslet.2007.06.017
25. Hardta SE, Sadoshima J (2004) Negative regulators of cardiac hypertrophy. Cardiovasc Res 63:500-509. doi: 10.1016/ j.cardiores.2004.03.015
26. Leesnitzer LM, Parks DJ, Bledsoe RK et al (2002) Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. Biochemistry 41:6640-6650. doi: 10.1021/bi0159581
27. Laidler P, Dulińska J, Mrozicki S (2007) Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines? Arch Biochem Biophys 462:1-12. doi: 10.1016/ j.abb.2007.03.013
28. Marx N, Duez H, Fruchart J-C et al (2004) Peroxisome proliferator-activated receptors and atherogenesis regulators of gene expression in vascular cells. Circ Res 94:1168-1178. doi: 10.1161/ 01.RES.0000127122.22685.0A
29. Eto Y, Yonekura K, Sonoda M et al (2000) Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation 101:2134-2137
30. Shimoyama M, Hayashi D, Zou Y et al (2000) Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. Circulation 102:1996-2004
31. Takeda Y, Yoneda T, Demura M et al (2002) Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation 105:677-679. doi: 10.1161/hc0602.104675
32. Saito T, Fukuzawa J, Osaki J et al (2003) Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy. J Mol Cell Cardiol 35:1153-1160. doi: 10.1016/S0022-2828(03)00234-7
33. Lim HW, Molkentin JD (1999) Calcineurin and human heart failure. Nat Med 5:246-247. doi: 10.1038/6430
34. Ritter O, Hack S, Schuh K et al (2002) Calcineurin in human heart hypertrophy. Circulation 105:2265-2269. doi: 10.1161/ 01.CIR.0000016044.19527.96
35. Molkentin JD (2004) Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475. doi: 10.1016/j.cardiores.2004.01.021
36. Hogan PG, Chen L, Nardone J et al (2003) Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17:2205-2232. doi: 10.1101/ gad.1102703
37. Hallhuber M, Burkard N, Wu R et al (2006) Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. Circ Res 99:626-635. doi: 10.1161/01.RES.0000243208.59795.d8
38. PGd Arco, Martínez-Martínez S, Maldonado JL et al (2000) A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp. J Biol Chem 275:13872-13878. doi: 10.1074/jbc.275.18.13872
39. Yang XY, Wang LH, Chen T et al (2000) Activation of human T lymphocytes is inhibited by peroxisome proliferator activated receptorγ (PPARγ) agonists. PPARγ co-association with transcription factor NFAT. J Biol Chem 275:4541-4544. doi: 10.1074/jbc.275.7.4541